Astellas Pharma
Jump to navigation
Jump to search
An Astellas Pharma is a Japanese multinational pharmaceutical company.
- Context:
- It can produce Astellas Pharmaceutical Products, such as: Xtandi, Prograf, Harnal, ...
- …
- Counter-Example(s):
- See: Oncology Therepeutic, Diabetes Medication.
References
2021
- (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Astellas_Pharma Retrieved:2021-11-3.
- {{is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of and . On February 5, 2020, the company announced management changes effective from April 1, 2020.
Astellas is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.
- {{is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of and . On February 5, 2020, the company announced management changes effective from April 1, 2020.
2021
- (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Astellas_Pharma#Products Retrieved:2021-11-3.
- Some of the key products produced by Astellas include:
- Adenocard (adenosine injection) – Pharmacologic stress agent for myocardial perfusion scan.
- Adenoscan (adenosine injection) – Pharmacologic stress agent for myocardial perfusion scan.
- AmBisome (amphotericin B) – Anti-fungal – marketed with Gilead Sciences.
- Amevive (alefacept) – plaque psoriasis.
- Astagraf XL (tacrolimus) – Prevention of post-transplant organ rejection.
- Cresemba (isavuconazole) – Anti-fungal.
- Enfortumab vedotin – Antibody-drug conjugate for the treatment of locally advanced or metastatic urothelial carcinoma
- Flomax (tamsulosin hydrochloride) – Benign prostatic hyperplasia (BPH)
- Flomax MR capsules were discontinued in 2005, replaced by Flomaxtra XL, containing the same active ingredient
- Lexiscan (regadenoson injection) – Pharmacologic stress agent for myocardial perfusion scan.
- Macugen (pegaptanib sodium) – Anti-angiogenic – marketed with Gilead Sciences in the US and Pfizer Outside of US.
- Mycamine (micafungin sodium) – Anti-fungal.
- Myrbetriq (mirabegron) – Overactive bladder (OAB) – US only marketed by Pfizer Outside of US.
- Padcev (enfortumab vedotin) - Bladder cancer.
- Prograf (tacrolimus) – Prevention of post-transplant organ rejection.
- Protopic (tacrolimus ointment) – Atopic dermatitis (eczema)
- Symoron (methadone HCL) – Opioid replacement therapy.
- Tarceva (erlotinib) – Non-small cell lung cancer and pancreatic cancer – marketed with Hoffmann-La Roche (Genentech).
- Vaprisol (conivaptan) – Hyponatremia.
- Vesicare (solifenacin succinate) – Overactive bladder (OAB)
- Vibativ (telavancin) – bactericidal lipoglycopeptide – marketed with Theravance.
- Xospata (gilteritinib) – AXL receptor tyrosine kinase.
- Xtandi (enzalutamide) – Prostate cancer – marketed with Pfizer.
- Some of the key products produced by Astellas include: